Medication Affordability and Patent Integrity Act requires drug and biological product sponsors to submit certain patent information to the FDA and.

The Medication Affordability and Patent Integrity Act mandates that sponsors of drug and biological product applications submit specific information to the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO). This includes any information material to patentability, such as analytical data from the chemistry, manufacturing, and controls section of a new drug application. Sponsors must also certify that the submitted information is consistent with what they provided to the USPTO and any communications they had with the FDA.

Medication Affordability and Patent Integrity Act requires drug and biological product sponsors to submit certain patent information to the FDA and.

The Medication Affordability and Patent Integrity Act mandates that sponsors of drug and biological product applications submit specific information to the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO). This includes any information material to patentability, such as analytical data from the chemistry, manufacturing, and controls section of a new drug application. Sponsors must also certify that the submitted information is consistent with what they provided to the USPTO and any communications they had with the FDA.